StreetInsider.com News Articles

Form 4 ALX ONCOLOGY HOLDINGS For: Jul 01 Filed by: Wong Shelly

Mon, 06 Jul 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260706/26735991.html

Form 4 ALX ONCOLOGY HOLDINGS For: Jul 01 Filed by: Wong Shelly

Mon, 06 Jul 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260706/26735991.html

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

Tue, 30 Jun 2026 16:40:00 -0400

SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, announced that the Compensation Committee of the Board of Directors of ALX Oncology approved the granting of an inducement stock option to purchase a total of 500,000 shares of ALX Oncology’s common stock to Michael Listgarten, General Counsel, on June 29, 2026 in connection with the commencement of his employment. Mr. Listgarten’s inducement stock option is subject to the terms of

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

Tue, 30 Jun 2026 16:40:00 -0400

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

Tue, 30 Jun 2026 16:40:00 -0400

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

Tue, 30 Jun 2026 16:40:00 -0400

Corey Goodman resigns as ALX Oncology board chairman

Tue, 30 Jun 2026 16:03:57 -0400

Corey Goodman, Ph.D., resigned as chairman and board member of ALX Oncology Holdings Inc. (NASDAQ: ALXO), effective June 29, 2026, according to a company statement.

The company stated that Goodman resigned for personal reasons and not due to any disagreement with the company regarding its operations, policies, or practices.

Corey Goodman resigns as ALX Oncology board chairman

Tue, 30 Jun 2026 16:03:57 -0400

Corey Goodman, Ph.D., resigned as chairman and board member of ALX Oncology Holdings Inc. (NASDAQ: ALXO), effective June 29, 2026, according to a company statement.

The company stated that Goodman resigned for personal reasons and not due to any disagreement with the company regarding its operations, policies, or practices.

Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 29

Tue, 30 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260630/26713432.html

Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 29

Tue, 30 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260630/26713432.html

ALX Oncology names new board chairman and general counsel

Tue, 30 Jun 2026 08:00:38 -0400

ALX Oncology Holdings Inc. (NASDAQ: ALXO) announced the appointments of Scott Garland as Chairman of the Board of Directors and Michael Listgarten as General Counsel, both effective immediately, according to a company press release.

Garland succeeds co-founder Corey Goodman, Ph.D., who is stepping down as Chairman and a member of the Board after more than a decade with the clinical-stage biotechnology company. Garland has served on the ALX Oncology board since November 2022 and brings more than 30 years of biopharmaceutical industry experience.

Goodman commented on the transition: "Scott is a highly respected leader with a strong track record and I am

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

Tue, 30 Jun 2026 08:00:00 -0400

Strengthens Leadership with Veteran Executives with Decades of Industry Experience

Scott Garland Succeeds Co-Founder Corey Goodman, Ph.D., After More Than a Decade of Foundational Leadership

Mr. Garland succeeds Corey Goodman, Ph.D., who is

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

Tue, 30 Jun 2026 08:00:00 -0400

Strengthens Leadership with Veteran Executives with Decades of Industry Experience

Scott Garland Succeeds Co-Founder Corey Goodman, Ph.D., After More Than a Decade of Foundational Leadership

Mr. Garland succeeds Corey Goodman, Ph.D., who is

Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 25

Fri, 26 Jun 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260626/26698620.html

Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 25

Fri, 26 Jun 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260626/26698620.html

Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 10

Thu, 11 Jun 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260611/26635527.html

Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 10

Thu, 11 Jun 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260611/26635527.html

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

Mon, 01 Jun 2026 08:00:00 -0400

SOUTH SAN FRANCISCO, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in a fireside chat presentation at the 2026 Jefferies Global Healthcare Conference in New York.

The details of the meeting are as follows:

2026 Jefferies Global Healthcare Conference in New York

Format: Fireside Chat Presentation
Date: June 3, 2026
Time: 5:30 PM ET
Webcast link: Available here

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

Mon, 01 Jun 2026 08:00:00 -0400

The details of the meeting are as follows:

2026 Jefferies Global Healthcare Conference in New York

Format: Fireside Chat Presentation
Date: June 3, 2026
Time: 5:30 PM ET
Webcast link: Available here

Form SCHEDULE 13D/A ALX ONCOLOGY HOLDINGS Filed by: LSV Associates, LLC

Wed, 27 May 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260527/26558146.html

Form SCHEDULE 13D/A ALX ONCOLOGY HOLDINGS Filed by: LSV Associates, LLC

Wed, 27 May 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260527/26558146.html

Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: Redmile Group, LLC

Fri, 15 May 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260515/26505937.html

Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: Redmile Group, LLC

Fri, 15 May 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260515/26505937.html

Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: HBM Healthcare Investments (Cayman) Ltd.

Fri, 15 May 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260515/26505191.html

Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: HBM Healthcare Investments (Cayman) Ltd.

Fri, 15 May 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260515/26505191.html